Specialities

Specialities

Respiratory Infections
Airway Diseases
Allergy
Asthma
Bronchiectasis
Bronchitis
Chronic Cough
COPD
COVID-19
Cystic Fibrosis
Idiopathic Pulmonary Fibrosis
Interstitial Lung Disease
Interventional Pulmonology
Lung Cancer
Paediatric Respiratory Medicine
Respiratory Tract Disorders
Pulmonary Embolism
Pulmonary Hypertension
Respiratory Intensive Care
Rhinosinusitis
Sleep Related Breathing Disorders
Lung Transplantation and Surgery
Ventilation
Lung Health
Rare Disease Day
Emphysema
Rare Diseases
Search

Trending Topic
14 mins

Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

The Impact of Smart Inhalers on Personalized Asthma Management

Kate Clair Cruden Hughes, Amy Hai Yan Chan

Asthma affects nearly 300 million people worldwide.1 Despite a notable decline in age-standardized prevalence, mortality and disability-adjusted life years over the past three decades, the burden of asthma remains high in many countries including low-middle-income countries.2 Climate change is also predicted to significantly impact asthma and other respiratory-related conditions, as rising global temperatures lead to longer pollen […]

touchREVIEWS in Respiratory & Pulmonary Diseases. 2025;10(1):Online ahead of journal publication

Connect With Us:

Facebook
X (Twitter)
Instagram
Youtube
Linkedin

Search Results

Showing Results for Antifibrotics

Speciality Filter

Select Specialty or Clinical Area

Clear All
Update Filters
Close Popup
Mark CompleteCompleted
BookmarkBookmarked

Diagnosis and Management of Fibrotic Interstitial Lung Disease: A Primer

Meenakshi Sridhar, Tejaswini Kulkarni

Interstitial lung diseases (ILDs) are a heterogeneous group of disorders characterized by inflammation and/or fibrosis.1 Pulmonary fibrosis develops due to repeated cycles of injury and impaired repair with fibroblast activation and migration with the resultant deposition of extracellular matrix ...

touchREVIEWS in Respiratory & Pulmonary Diseases. 2024;9(1):29-36
Coverage from: ATS Highlights

Clinical trials and current standard of care in idiopathic pulmonary fibrosis: Steven D. Nathan, ATS 2023

View Coverage

Latest articles videos and clinical updates - straight to your inbox

Close Popup